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Abstract
The PPCD1 mouse, a spontaneous mutant that arose in our mouse colony, is characterized by an enlarged anterior chamber
resulting from metaplasia of the corneal endothelium and blockage of the iridocorneal angle by epithelialized corneal
endothelial cells. The presence of stratified multilayered corneal endothelial cells with abnormal patterns of cytokeratin
expression are remarkably similar to those observed in human posterior polymorphous corneal dystrophy (PPCD) and the
sporadic condition, iridocorneal endothelial syndrome. Affected eyes exhibit epithelialized corneal endothelial cells, with
inappropriate cytokeratin expression and proliferation over the iridocorneal angle and posterior cornea. We have termed
this the ‘‘mouse PPCD1’’ phenotype and mapped the mouse locus for this phenotype, designated ‘‘Ppcd1’’, to a 6.1 Mbp
interval on Chromosome 2, which is syntenic to the human Chromosome 20 PPCD1 interval. Inheritance of the mouse
PPCD1 phenotype is autosomal dominant, with complete penetrance on the sensitive DBA/2J background and decreased
penetrance on the C57BL/6J background. Comparative genome hybridization has identified a hemizygous 78 Kbp
duplication in the mapped interval. The endpoints of the duplication are located in positions that disrupt the genes Csrp2bp
and 6330439K17Rik and lead to duplication of the pseudogene LOC100043552. Quantitative reverse transcriptase-PCR
indicates that expression levels of Csrp2bp and 6330439K17Rik are decreased in eyes of PPCD1 mice. Based on the
observations of decreased gene expression levels, association with ZEB1-related pathways, and the report of corneal
opacities in Csrp2bp
tm1a(KOMP)Wtsi heterozygotes and embryonic lethality in nulls, we postulate that duplication of the 78 Kbp
segment leading to haploinsufficiency of Csrp2bp is responsible for the mouse PPCD1 phenotype. Similarly, CSRP2BP
haploinsufficiency may lead to human PPCD.
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Introduction
The inherited human corneal endothelial dystrophies, posterior
polymorphous corneal dystrophy (PPCD), congenital hereditary
endothelial dystrophy (CHED), and Fuchs endothelial dystrophy
(FECD), are characterized by abnormal development, dysfunction
and/or proliferation of the corneal endothelium [1,2,3]. These
corneal dystrophies and the sporadic disorder, iridocorneal
endothelial syndrome (ICE), exhibit overlapping clinical and
pathological features, including ultrastructural changes and
abnormal patterns of cytokeratin expression consistent with
epithelialization[4,5,6]. Human PPCD is characterized by the
presence of abnormal corneal endothelial cells which display
epithelial features including microvilli and inappropriate cytoker-
atin expression[2,6,7] Clinical outcomes vary from minimal visual
impairment to an aggressive course, with development of retro-
corneal membranes and corneal opacification requiring kerato-
plasty [8,9,10]. Glaucoma has been reported at frequencies
ranging from 10%–40% in different PPCD pedigrees [11]. ICE
is also associated with increased intraocular pressure and
development of glaucoma [12].
Human PPCD, like many eye disorders, exhibits genetic
heterogeneity and has been linked to three chromosomal loci,
10p11, 20p11.2, and 1p34.3-p32. The transcription factor ZEB1
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12213gene, at 10p11, is the best characterized PPCD gene (PPCD3,
MIM #609141) [13,14,15,16]. Recently, missense mutations in
ZEB1 in association with a locus on chromosome 9 have also been
linked to FECD [17]. In addition, PPCD in a number of families
has been localized to an interval on chromosome 20p11.2 (PPCD1,
MIM #122000) [11,18,19] that overlaps the region linked to
CHED1, the autosomal dominant form of CHED [19,20]. The
coding regions of the 26 human PPCD1 candidate genes located in
the region common to three PPCD1 pedigrees, plus 9 adjacent
genes linked to CHED1, have been sequenced, but no causative
mutations have been found [21,22,23]. Finally, mutations in the
COL8A2 gene, located on chromosome 1 and encoding the alpha-
2 chain of type VIII collagen, have been associated with both
PPCD (PPCD2, MIM #609140) and FECD [24,25].
In the course of gene targeting studies designed to disrupt the
murine Cypor locus [26], we observed mice with enlarged eyes in
progeny derived from one of the targeted embryonal stem (ES) cell
clones. This phenotype, which we termed mouse PPCD1,
segregated independently from the targeted Cypor gene and
appeared to be the result of a spontaneous mutation at an
unknown location within the genome of the ES cells. PPCD1 mice
exhibit an enlarged anterior chamber as a consequence of
epithelialization of the corneal endothelium and proliferation of
these epithelialized cells into the iridocorneal angle. These
characteristics closely resemble that observed in the human PPCD
and ICE. The possibility that the PPCD1 mouse could serve as a
model for human PPCD or ICE led us to characterize the murine
phenotype and identify its genetic basis.
Results
Origin of the PPCD1 mouse
Four founder males, all derived from the ES cell clone
designated G1, gave rise to progeny exhibiting the phenotype of
an enlarged anterior chamber that we designate as mouse PPCD1
(Fig. 1A). Both eyes are affected and males and females are equally
affected. Animals derived from a separate ES clone (H11) from
these same Cypor targeting experiments did not exhibit enlarged
eyes. Initial ophthalmoscopic examinations to characterize the
mouse PPCD1 phenotype were carried out on 3–5-month-old
animals (49 PPCD1 and 30 normal littermates) on the mixed 129/
B6 background. These exams revealed a deep anterior chamber
and corneal abnormalities including corneal haze, neovascular-
ization, ulcers and scarring. Posterior and anterior synechiae, lens
subluxation, and phthisis were also observed. None of these
phenotypes were observed in normal littermates. Genotyping
established that the PPCD1 phenotype was independent of the
targeted Cypor allele. Absence of the neo resistance cassette in
PPCD1 animals was also confirmed (data not shown). All
subsequent studies were carried out using PPCD1 animals wild-
type at the Cypor locus.
Anterior segment abnormalities of PPCD1 mice
Microscopic examination at low power of enucleated, formalin-
fixed eyes from 3-month-old PPCD1 animals backcrossed to
DBA/2J for 8 generations reveals an increase in the depth of the
anterior chamber (Figure 1B). Measurements of fixed eyes from 3-
month-old animals indicate that the increased depth of the
anterior chamber results in a 41% increase in the overall length of
affected eyes, from 3.3460.13 mm (n=10) in normal animals, to
4.7060.35 mm (n=10) in PPCD1 littermates (P,0.001). The
overall diameter of the eye is also increased, by 19%, from
3.3060.08 mm to 3.9160.16 mm (P,0.001). Other findings
shown in Figure 1 include corneal haze and neovascularization
(observed in over 80% of affected eyes), corneal scarring,
proliferation of cells over the surface of the lens, lens subluxation,
synechiae, and phthisis. None of these abnormalities are observed
in normal littermates.
Histological examination of paraffin sections from PPCD1 eyes
reveals distension of the anterior chamber (Figure 2B) and
occlusion of the trabecular meshwork by multilayered, stratified
endothelial cells (Figure 2D). These cells exhibit an epithelial
morphology and are visible in the iridocorneal angle and on the
posterior surface of the cornea and anterior surface of the iris
(Figure 2D). Migration of these abnormal cells onto the central
cornea is also observed (Figure 2F). In some affected eyes, thinning
of the central cornea is observed. Corneas of PPCD1 animals, but
not normal littermates, also display F4/80-immunoreactive cells,
indicative of increased macrophage infiltration (Figure 2H). Other
features associated with the mouse PPCD1 phenotype include
corneal neovascularization (Figure 2I) and anterior synechias
(Figure 2J).
In PPCD1 animals, affected eyes exhibit inappropriate
cytokeratin AE1/AE3 immunoreactivity in the corneal endothe-
lium and iridocorneal angle, extending onto the anterior surface of
the iris and posterior surface of the cornea (Figure 3A). Figure 3C
shows cytokeratin AE1/AE3-positive cells extending across the
posterior surface of the central cornea in a 3-month old PPCD1
Figure 1. Phenotypic appearance of mouse PPCD1. Enucleated eyes were fixed in 10% formalin in phosphate-buffered saline and
photographed. A. Appearance of PPCD1 mouse, showing the enlarged anterior chamber. B. Comparison of normal (left) and affected (right) eyes.
Corneal neovascularization can be observed on the surface of the affected cornea. The arrow indicates an anterior synechia. Age, 3 months. C.
Affected eye, showing corneal haze and cell growth across the surface of the pupil (arrow). Age, 3 months. D. Affected eye, showing lens subluxation,
corneal haze, exudate in the anterior chamber, and anterior synechia. Age, 5 months.
doi:10.1371/journal.pone.0012213.g001
Mouse Corneal Dystrophy Model
PLoS ONE | www.plosone.org 2 August 2010 | Volume 5 | Issue 8 | e12213animal. Eyes from normal littermates exhibit appropriate patterns
of cytokeratin AE1/AE3 immunoreactivity, with positive staining
of corneal epithelium but not corneal endothelium (Figure 3, B
and D).
Effect of genetic background on the PPCD1 phenotype
To assess the effects of genetic background on penetrance of the
PPCD1 phenotype, PPCD1 mice on the DBA/2J background (N8
generation) were mated with either FVB/N or C57BL/6J (B6)
Figure 2. Histology of affected eyes. Eyes were fixed in 10% formalin in phosphate-buffered saline, processed, and stained with hematoxylin and
eosin as described in Materials and Methods. Genotypes are indicated at the upper left. D2, DBA/2J; AC, anterior chamber; c, cornea; ce, corneal
epithelium; cn, corneal endothelium; Ir, iris; s, synechia. A. Normal eye, age 2.5 months. B. PPCD1 eye, age 2.5 months. C. Normal iridocorneal angle,
age 3 months. D. PPCD1 iridocorneal angle, age 3 months. Arrowheads indicate multilayered, stratified endothelial cells. E.`Normal cornea, age 3
months. F. PPCD1 cornea showing multilayered, stratified endothelial cells on the posterior surface of the central cornea (arrowhead), age 3 months.
G. F4/80 immunohistochemistry of normal cornea, age P19. H. F4/80 immunohistochemistry of PPCD1 cornea, age P19. F4/80-positive cells stain
reddish-brown. I. Corneal neovascularization (asterisks), age 3 months. J. Anterior synechia, age 5 months.
doi:10.1371/journal.pone.0012213.g002
Mouse Corneal Dystrophy Model
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P,.05) and 44% (n=44, P,0.2), respectively, for the PPCD1 x
B6 F1 and PPCD1 x FVB/N F1 animals, consistent with
autosomal dominant transmission and decreased penetrance on
the B6 background. Further backcrossing to B6 resulted in loss of
the PPCD1 phenotype after three generations of backcrossing.
The size of the anterior chamber in affected F1 animals was
comparable to that seen on the DBA/2J background.
Development of the mouse PPCD1 phenotype
Histological examination of the developing iridocorneal angle
immediately after birth and at postnatal day 2 (P2) reveals no
apparent differences between wild-type and PPCD1 (Fig. 4, B and
D). At P3, stratified and multilayered corneal endothelial cells are
visible and cells in the iridocorneal angle appear to be more
densely packed (Fig. 4, F and G). At P5, the iridocorneal angle is
obviously occluded (Fig. 4H), with observable distension of the
anterior chamber.
Chromosomal localization of mouse PPCD1
In crosses between PPCD1 and DBA/2J mice (N5 through N8,
n=204), 52% of the offspring exhibited big eyes, consistent with
autosomal dominant inheritance at a single locus, designated
Ppcd1, and complete penetrance in the DBA/2J background.
Linkage of the Ppcd1 mutation to agouti was observed in the initial
backcrossing experiments. This was confirmed by genotyping with
the simple sequence length polymorphism (SSLP) markers
D2Mit22 and D2Mit26, located at 151.8 and 151.3 Mbp,
respectively, on Chromosome 2, which indicated that 57/57 BE
animals, but 0/28 normal animals, carried one 129 ES cell-derived
allele at these loci. Further backcrossing (to N9) produced a
nonagouti PPCD1 animal that was heterozygous for 129-derived
markers from D2Mit306, at 135.1 Mbp, to rs13470055,a t
150.44 Mbp. Linkage analysis of animals produced from back-
crossing progeny of this animal to DBA/2J is presented in Figure 5
and places the Ppcd1 mutation on Chromosome 2, between the
markers D2Mit259, at 142.2 Mbp, and D2Mit282, at 148.3 Mbp.
In an effort to obtain homozygous null animals, PPCD1
heterozygous animals with enlarged eyes and carrying one 129-
derived allele between the markers D2Mit259 and D2Mit282 were
intercrossed. Of a total of 149 progeny, no live pups homozygous
for the 129-derived allele or displaying enlarged eyes have been
found, suggesting that homozygosity of the Ppcd1 mutation or a
closely linked gene causes embryonic lethality. Genotyping of
embryos at embryonic days 9.5 (n=22) and 10.5 (n=12) have also
not yielded homozygous progeny.
Comparative genome hybridization
To determine if a gross chromosomal rearrangement was
responsible for the mouse PPCD1 phenotype, comparative
genome hybridization was carried out on DNA from wild-type
and PPCD1 animals using the Nimblegen 395 K Whole Genome
8 Array Tiling Set, which contains 385,000 50-75mer probes
covering mouse Chromosome 2 from 124 Mbp to 181.9 Mbp at
an average spacing of 656 bp. Three separate comparisons
between PPCD1 and wild-type DNA each identified a single
increased copy number segment on Chromosome 2 (Figure 6).
Comparison of DNA from PPCD1 animals with wild-type
littermates identified an 87,103 bp segment extending from
144,220,537 bp to 144,307,640 bp on Chromosome 2 and
comprised of 122 probes. Comparison of DNA from PPCD1
animals with DNA from the 129/Sv-derived R1 ES cells used for
Figure 3. Cytokeratin AE1/AE3 immunohistochemistry of affected eyes. Positive cells are reddish-brown. Genotypes are indicated at the
upper left. D2, DBA/2J; ce, corneal epithelium; cn, corneal endothelium; AC, anterior chamber; IR, iris. A. Iridocorneal angle of PPCD1 animal, age P19.
Arrows indicate epithelialized endothelium. B. Iridocorneal angle of normal littermate, age P19, showing absence of immunoreactivity in the
corneal endothelium and iridocorneal angle. C. Central cornea of 3-month old PPCD1 animal showing cytokeratin AE1/AE3 immunoreactivity of both
corneal endothelium and epithelium. D. Central cornea of 3-month old normal littermate showing cytokeratin AE1/AE3 immunoreactivity of corneal
epithelium only.
doi:10.1371/journal.pone.0012213.g003
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from 144,225,647 bp to144,304,372 bp. Comparison of DNA
from G1 and H11 ES cell clones, which gave rise to PPCD1 and
normal progeny, respectively, also identified this segment,
extending from 144,223,757 Mbp to 144,303,650 bp. The
variability in the endpoints arises from inclusion or exclusion of
5 probes with log2ratios of approximately 0.2 at the endpoints of
the segments by the CGH-segMNT algorithm. The 78 Kbp
Figure 4. Development of the mouse PPCD1 phenotype. The iridocorneal angle from normal eyes (A, C, and E) is compared with that of
PPCD1 littermates (B, D, F, and G). Panel H shows the PPCD1 iridocorneal angle at P5. Genotypes are indicated at the upper left. D2, DBA/2J; AC,
anterior chamber; c, cornea. A. Normal, P0. B. PPCD1, P0. C. Normal, P2. D. PPCD1, P2. E. Normal, P3. F. PPCD1, P3. G. PPCD1, P3, enlarged to show
layering of corneal endothelial cells (arrow). H. PPCD1, P5.
doi:10.1371/journal.pone.0012213.g004
Figure 5. Chromosomal localization of Ppcd1 locus. Shaded boxes indicate the129 (PPCD1) allele. Open boxes indicate the DBA/2J (normal eye)
allele. SSLP markers analyzed are indicated on the left. Numbers of animals of each haplotype are indicated at the bottom.
doi:10.1371/journal.pone.0012213.g005
Mouse Corneal Dystrophy Model
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extends from 144,225,647 to 144,303,650 bp, with an uncertainty
of 5 and 4 Kbp, for assignment of the proximal and distal
breakpoints, respectively. The observed log2ratios of 0.24, 0.38,
and 0.48 are consistent with the presence of a hemizygous
duplication in the BE animals.
Two genes, Csrp2bp and 6330439K17Rik, and one pseudogene,
LOC100043552, are located in this segment. The predicted
endpoints of the duplication are located between Exons 7 and 8
of Csrp2bp and between Exons 17 and 20 of 6330439K17Rik,
presumably disrupting both genes. LOC100043552, located in the
center of the sequence, is presumably duplicated and not
disrupted. No other Chromosome 2 copy number variations were
detected on this chip. From our mapping data, it is highly unlikely
that disruption of a gene outside the 6.1 Mbp interval is
responsible for mousePPCD1; thus it is likely that one of these
three genes is the Ppcd1 gene.
Microarray analysis (not shown) and qPCR of these three
transcripts indicates that all three are transcribed and that
expression of Csrp2bp and 6330439K17Rik is decreased in PPCD1
eyes compared to wild-type at both 16 and 28 days. Figure 7 shows
that expression levels of Csrp2bp and 6330439K17Rik in PPCD1
eyes at 28 days are approximately half that of wild-type.
Expression of LOC100043552 is not significantly different between
the two genotypes (not shown).
Discussion
The mouse PPCD1 phenotype is characterized by abnormal
growth of epithelialized corneal endothelial cells over the
iridocorneal angle, posterior cornea, and iris and presents with
early onset of an enlarged anterior chamber. The spectrum of
ocular abnormalities associated with the mouse PPCD1 phenotype
has not been previously observed in other mouse ocular mutants.
The presence of corneal endothelial cells with epithelial features
including microvilli and cytokeratin expression is a characteristic
of the human autosomal dominant disorder PPCD, as well as ICE,
a sporadic condition of unknown etiology [2,6,7].
Corneal endothelial cell metaplasia is the earliest observable
mouse PPCD1 phenotype in this study, as shown by histology at
postnatal day 3. We postulate that occlusion of the trabecular
meshwork in the developing eye by epithelialized corneal
endothelial cells leads to the visibly enlarged anterior chamber.
Ocular enlargement, occlusion of the trabecular meshwork, and
development of synechias are often associated with increased
intraocular pressure and the question of whether PPCD1 mice
develop glaucoma is currently under investigation.
The PPCD1 mouse arose spontaneously in the course of gene
targeting experiments employing the R1 ES cell line. The mouse
PPCD1 phenotype has not been reported in any of the large
number of R1 - derived recombinant mouse lines that have been
generated in our and other laboratories. Genetic analysis
demonstrates that the mouse PPCD1 phenotype is unrelated to
the presence of the Cypor null allele and the absence of the neo gene
indicates that mouse PPCD1 is not due to a secondary insertion of
the targeting vector at a nonhomologous site. Taken together,
these observations suggest that the mouse PPCD1 phenotype is
due to a spontaneous mutation in the G1 ES cell clone used in the
Cypor targeting experiments.
As with human PPCD, transmission of the mouse PPCD1
phenotype is autosomal dominant. Murine null alleles of proposed
human candidate genes, including VSX1 [27] and COL8A1 [28]
null mice and the T27aT15 mouse[29], have not reproduced the
corneal endothelial cell abnormalities seen in human PPCD.
Recently, Zeb1-null embryos have been reported to exhibit ectopic
expression of epithelial genes, abnormal corneal endothelial and
keratocyte proliferation, corneal thickening, and corneolenticular
and iridocorneal adhesions. Adult heterozygotes exhibit corneal
thickening, increased keratocyte number, and iridocorneal and
corneolenticular adhesions [30]. Like Zeb1 heterozygotes, adult
Figure 6. CGH Analysis. Log2ratio is shown in the lower panel and transcripts (green lines) in the top panel. Coordinates in Mbp are shown at the
top. The log2ratio values are indicated by blue (PPCD1 versus DBA/2J), red (PPCD1 versus R1 ES cells), or green (G1 versus H11) dots. The solid lines
indicate segments identified by the Nimblegen CGH-segMNT algorithm. Arrows indicate the direction of transcription. A, Csrp2bp;B ,LOC100043552;
C, 6330439K17Rik.
doi:10.1371/journal.pone.0012213.g006
Figure 7. qPCR of Csrp2bp and 6330439K17Rik. Expression levels
were determined using IDT Prime Time
TM 59- nuclease assays. Values
are mean +/2 SD. Black shows wild-type values and gray, PPCD1 values.
P values are 0.01 and 0.02, for Csrp2bp and 6330439K17Rik, respectively.
doi:10.1371/journal.pone.0012213.g007
Mouse Corneal Dystrophy Model
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PPCD1 animals differs from that of Zeb1-haploinsufficient animals
in that the phenotype is not morphologically apparent until after
birth and proliferation of epithelialized corneal endothelial cells
into the iridocorneal angle, with angle occlusion, is observed.
Our mapping studies place the Ppcd1 locus on mouse
chromosome 2, between the markers D2Mit259 and D2Mit282.
This 6.1 Mbp region of Chromosome 2 is largely syntenic with the
region on human chromosome 20 implicated in human PPCD
(Fig. 8). Comparative genome hybridization reveals a 78 Kbp
hemizygous duplication located between 144.2 and 144.3 Mbp,
with some uncertainty in assignment of the endpoints. Regardless
of the choice of endpoints, this duplication which has the potential
to disrupt expression of 2 genes, 6330439K17Rik and Csrp2bp, and
produce two copies of the pseudogene LOC100043552. qPCR
indicates that expression of 6330439K17Rik and Csrp2bp are
decreased in PPCD1 eyes compared to wild-type, while levels of
LOC100043552 are not different between the two genotypes.
6330439K17Rik is the mouse ortholog of human C20ORF12;
both genes contain two ankyrin repeat-encoding regions (http://
www.ncbi.nlm.nih.gov/cdd) and their function is unknown.
Although LOC100043552 is classified as a pseudogene based on
the presence of multiple termination codons, it exhibits 81% DNA
homology to its human ortholog, ZNF133, with conservation of
the zinc finger motifs but not the KRAB domain. The in vivo
function of ZNF133 is unknown, but it has been shown to function
as a transcriptional repressor in vitro [31].
CSRP2BP, also known as ATAC2, is a component of mammalian
ATAC, a histone acetyltransferase complex shown to have
essential functions in mammalian development [32,33]. Another
component of the ATAC complex is PCAF, a protein shown to be
recruited by ZEB1 [34]. A Csrp2bp-null mouse, generated from
129-derived ES cells and maintained on the C57BL/6J back-
ground, has been reported to be embryonic-lethal at E9.5 [33]. No
eye abnormalities in heterozygotes have been reported. However,
a second, targeted knockout, Csrp2bp
tm1a(KOMP)Wtsi , in which Exon
3 has been deleted, has been generated by the Wellcome Trust
Sanger Institute and exhibits corneal opacities in heterozygotes
and embryonic lethality in homozygotes (http://www.sanger.ac.
uk/mouseportal/search/MGI:1917264. Based on the observa-
tions of decreased gene expression levels, association with ZEB1 -
related pathways, and the report of corneal opacities in
heterozygotes and embryonic lethality in the null, we postulate
that haploinsufficiency of Csrp2bp is responsible for the mouse
PPCD1 phenotype.
The coding regions of human C20ORF12, Csrp2bp and ZNF133
have been sequenced from DNA from the human PPCD1
pedigree described by Yellore et al. [19,21], but no mutations
segregating with PPCD in these families were identified. Mutations
in coding regions are only one of a number of possible disease-
causing genetic variations, as has been discussed by Aldave et al.
[21].
Human developmental eye disorders are characterized by
variable penetrance [35]; likewise genetic background influences
the penetrance of the mouse PPCD1 phenotype. Penetrance of
mouse PPCD1 is decreased in the C57BL/6J background
compared to DBA/2J. DBA/2J mice are known to develop iris
pigment dispersion and stromal atrophy leading to increased
intraocular pressure and glaucoma. Although the anterior segment
abnormalities seen in PPCD1 mice are distinct from those of
DBA/2J, it is possible that common developmental pathways are
affected.
In summary, the PPCD1 mouse is a model of human anterior
segment dysgenesis with features of PPCD and ICE. Histological
similarities, autosomal dominant transmission, and linkage to a
region of chromosome 2 syntenic to the human PPCD1 locus
provide evidence that the PPCD1 mouse is a bona fide model of
human PPCD. Epithelialization of the corneal endothelium and
early onset distinguish the PPCD1 mouse from other mouse
models of anterior segment dysgenesis. We have localized the
Ppcd1 gene to a 6.1 Mbp region of mouse chromosome 2 which is
syntenic to a human PPCD locus. Comparative genome
hybridization has identified a hemizygous duplication in this
region which disrupts expression of two genes, Csrp2bp and
6330439K17Rik. We propose that Csrp2bp is the Ppcd1 gene and we
are in the process of testing that hypothesis through development
of corresponding mutant mouse alleles. The ability to manipulate
expression of the mouse PPCD1 phenotype in different strains
may provide important insights into how genes interact to
influence ocular disease in mammalian systems.
Methods
Origin of the PPCD1 mouse
The PPCD1 mouse arose from gene targeting experiments
designed to generate a null allele at the Cypor locus [26]. The R1
Figure 8. Comparison of mouse and human PPCD1 loci. Mouse chromosome 2 is shown on the upper line and human chromosome 20 on the
lower line. Chromosomal positions in Mbp are shown at the bottom, with the relative positions on human chromosome 2 shown in parentheses.
Microsatellite markers used to define the mouse and human critical intervals are labelled. Bar A indicates the critical interval for mouse Ppcd1 (see
below) and bars B and C indicate the PPCD1 critical intervals defined by Gwilliam et al. [18] and Yellore et al.[19], respectively. Mouse genes and
markers are indicated by diamonds and human genes and markers are indicated by triangles. Lines connect orthologous genes.
doi:10.1371/journal.pone.0012213.g008
Mouse Corneal Dystrophy Model
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129/Sv6129/Sv-CP embryos [36]. After injection of recombi-
nant ES cells into B6 blastocysts, chimeras were crossed to the B6
strain to identify germ line transmission. Two separate ES cell
clones, designated G1 and H11, gave rise to separate mouse lines
that transmitted the targeting event at the Cypor locus. Four
founder males derived from the G1 clone each gave rise to mice
that displayed an enlarged anterior chamber. The H11 ES cell
line gave rise to mice displaying normal ocular physiology.
Animals derived from the G1 clone and exhibiting an enlarged
anterior chamber, designated PPCD1, were maintained on a
129/B6 mixed background for 3 generations. To produce a
congenic PPCD1 line on the DBA/2J background, PPCD1
animals wild-type at the Cypor locus were backcrossed to DBA/2J
mice for 20 generations. PPCD1 animals were identified by the
presence of a visibly enlarged anterior chamber (see Fig. 1A); all
phenotype assignments were confirmed by examination of
enucleated eyes under a dissecting microscope. To investigate
the effect of genetic background, PPCD1 mice crossed onto the
DBA/2J background for 8 generations were mated to either B6
or FVB/N mice and scored for the presence of an enlarged
anterior chamber.
Characterization of the mousePPCD1 phenotype
All procedures conformed to the principles embodied in the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research (www.arvo.org). Procedures were also ap-
proved by the Animal Care and Use Committee, School of
Medicine and Public Health, University of Wisconsin-Madison
(Protocol Number M00578-0-11-07). Initial clinical character-
ization of the mouse PPCD1 phenotype was carried out on a
g r o u po f4 9P P C D 1a n d3 0n o r m a ll i t t e r m a t e so nt h em i x e d
129/B6 background (3–5 months old). Indirect ophthalmosco-
py was performed using a Welch Allyn ophthalmic headset
fitted with a 28 diopter Nikon individual lens. Mouse pupils
were dilated with a solution containing 1.0% (w/v) tropic-
amide, 2.5% (w/v) phenylephrine, delivered using a blunted 30
gauge needle.
All subsequent phenotype scoring and characterization have
been carried out by examination of formalin-fixed eyes under a
dissecting microscope, using animals backcrossed to DBA/2J for
at least 8 generations, Animals were sacrificed by CO2
inhalation and enucleated eyes were fixed overnight in 10%
(v/v) formalin in phosphate-buffered saline, pH 7.2. Fixed eyes
were rinsed with phosphate-buffered saline and scored under a
dissecting microscope for the presence of ocular and anterior
chamber enlargement, corneal neovascularization, corneal
h a z e ,s y n e c h i a e ,l e n ss u b l u x a t i o n ,c o r n e a ls c a r r i n g ,a n dp h t h i s i s .
Animals exhibiting an enlarged anterior chamber were scored as
PPCD1.
For histological characterization, eyes were formalin-fixed,
dehydrated in graded ethanol, and processed for routine
paraffin embedded light microscopy. Sections were stained
with hematoxylin and eosin (H&E) or by immunohistochem-
istry. Primary antibodies used were anti-human cytokeratin
[Clones AE1/AE3 (DAKO, Carpenteria CA)] or anti-mouse
F4/80 (Serotec, Oxford UK). Primary antibody was omitted
from negative controls. Following incubations with primary
antibodies, sections were incubated with biotinylated second-
ary antibody and avidin-conjugated peroxidase using the
Vectastain ABC kit and NovaRed substrate according to the
manufacturer’s instructions (Vector Laboratories, Burlingame
CA).
Genetic Mapping
Tail DNA was isolated using the Puregene reagent according to
the manufacturer’s instructions (Gentra, Minneapolis MN). G1
and H11 ES cell DNA was isolated from the expanded cell
preparations used for microinjection into blastocysts. DNA from
embryonal stem cells lines was isolated by Proteinase K and
RNase digestion followed by phenol extraction and ethanol
precipitation. Genotyping for the Cypor gene was carried out as
described [26]. The Mouse Genome Informatics database (www.
informatics.jax.org) was searched to identify SSLP and single
nucleotide polymorphism (SNP) markers polymorphic for the
129X1/SvJ, C57BL/6J, and DBA/2J strains. The following SSLP
markers were chosen for use in linkage analysis: D2Mit 306,
D2Mit259, D2Mit166, D2Mit282, D2Mit26, and D2Mit22. Micro-
satellite markers were amplified using 1 ml DNA (,20 ng), 0.2 mM
each primer, 50 mM dNTPs, 1x polymerase chain reaction (PCR)
buffer (Roche; 10 mM Tris–HCl, pH 8.3, 1.5 mM MgCl2,
50 mM KCl) and 0.5 U Taq polymerase in a final reaction
volume of 20 ml. Reactions were incubated in an MJ PTC-200
thermal cycler at 94uC for 2 min and then for 40 cycles of 94uC
for 30 sec, 55uC for 40 sec, 72uC for 60 sec and 72uC for 5 min.
The products were separated by electrophoresis through a 4%
MetaPhor agarose gel (Lonza). The SNP markers rs33188601 and
rs13470055 were analyzed by PCR amplification of the region
flanking the SNP followed by DNA sequencing. DNA sequencing
was carried out using the BigDye protocol (Applied Biosystems)
according to the manufacturer’s directions; electrophoresis was
carried out at the UW DNA Sequencing Facility. To confirm that
these markers were indeed informative, each marker was tested on
genomic DNA from DBA/2J, B6, and the G1 ES cells from which
these animals were derived.
Comparative genome hybridization
DNA from tails or ES cells was prepared as described above and
analyzed by Nimblegen CGH Services. Tail DNA samples were
prepared by pooling DNA from three wild-type or PPCD1
animals (littermates). Samples were hybridized to the MM8 WG
CGH 2 of 8 (B4351-02-01) chip, which contains probes covering
the following mouse DNA sequences: Chr2, 123,962,199 bp to
181,926,640 bp; Chr3, 3,000,451 bp to 159,871,498 bp; and
Chr4, 3,006,937 bp to 108,173,152 bp. Data was analyzed by
Nimblegen using their CGH-segMNT algorithm.
Gene expression
Immediately after CO2 euthanasia, eyes were enucleated and
placed in RNAlater (Qiagen). Total RNA was isolated using the
Qiagen RNeasy Mini kit. First strand cDNA synthesis was carried
with random hexamer primers and Superscript reverse transcrip-
tase according to the manufacturer’s directions. 59-nuclease primer
pairs and probes were designed and synthesized by Integrated
DNA Technologies. For Csrp2bp, the primer pair used was 59-
ACATCCCAACCATCAACTCC -39 and 59-TCACATCAG-
GAACCATGAAGC-39, with the labelled probe 59-CAGA-
CACTCAGACAGGTCAATGCCA-39, which amplified a se-
quence extending from Exon 9 to Exon 10. For 6330429K17Rik,
the primer pair used was 59-TGCCAC TGTCCATGAAGATG-
39 and 59-GTCATATAGCCCGTTCCCAC-39, with the labeled
probe 59-AAGAGCCTGTACTTCAACAAGTCGGTG-39. This
amplified a sequence from Exon 15 to Exon 16. 59- nuclease assays
were carried out using Taqman Universal PCR Master Mix from
Applied Biosystems according to the manufacturer’s instructions
and were run on a BioRad Icycler, using the following conditions:
95uC, 10 min,; 40 cycles [95uC, 10 sec; 60uC, 30 sec], 95uC,
1 min.
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